AYOXXA

AYOXXA Biosystems is a biotechnology company specializing in translational proteomics, focusing on multiplex protein analysis for biomarker quantification. The company serves leading scientists and researchers in the fields of ophthalmology, immune responses, and immuno-oncology. Operating within the life sciences market, AYOXXA's business model revolves around providing a scalable and integrated platform that includes proprietary technology, dedicated readers, and intuitive software for data analysis. This platform allows for the quantification of up to 12 biomarkers in minimal sample volumes, offering transparent assay outcomes and superior data quality. AYOXXA generates revenue through the sale of its multiplex protein analysis systems and associated consumables, as well as through research collaborations and partnerships. The company’s technology is validated for various biofluids, tissue samples, and cell cultures, making it versatile for both basic research and clinical applications.

Keywords: multiplex protein analysis, biomarker quantification, translational proteomics, ophthalmology, immune responses, immuno-oncology, scalable platform, proprietary technology, data analysis, life sciences.